Functional precision medicine using drug sensitivity testing enables tailoring of therapy for leukemia patients
A functional precision medicine study conducted in Finland demonstrates that treatment selection based on results from drug sensitivity testing of patients' cells can be clinically useful in patients with aggressive…
Uusi keuhkosyövän biomarkkeri voi auttaa ennustamaan immuuniterapioiden sopivuutta potilaille
iCANin tutkijoiden tunnistama uusi biomarkkeri ennakoi syöpäkasvaimen kykyä estää kehon immuunijärjestelmän toimintaa.
iCAN researchers identify new biomarker with potential to predict immunotherapy response in lung cancer
The newly discovered biomarker may help to distinguish which patients are more likely to benefit from immunotherapies.